Latest news
ARCT: Advanced rare disease pipeline and regained global vaccine rights, with strong cash runway through 2028 - TradingViewTradingView · Thu, 06 Aug 2026 22:19:18 GMTEVMN: Strong cash reserves support key clinical milestones despite higher losses and no Q2 revenue - TradingViewTradingView · Thu, 06 Aug 2026 20:24:31 GMTACRS: Higher net loss and R&D spend offset by strong cash reserves and major clinical milestones ahead - TradingViewTradingView · Thu, 06 Aug 2026 11:16:28 GMTIRD: Gene therapy pipeline advances with strong cash position and key clinical milestones ahead - TradingViewTradingView · Thu, 06 Aug 2026 11:15:39 GMTGLUE: Clinical pipeline advanced with multiple Phase 2 studies; cash runway extends into 2029 - TradingViewTradingView · Thu, 06 Aug 2026 11:14:35 GMTTNYA: Strong clinical progress and extended cash runway offset by higher net loss from impairment - TradingViewTradingView · Wed, 05 Aug 2026 20:24:44 GMTRCUS: Advanced casdatifan in ccRCC, secured new partnerships, and maintained strong cash runway - TradingViewTradingView · Wed, 05 Aug 2026 20:14:38 GMTRXRX: Reduced 2026 cash opex guidance, strong cash runway, and major clinical milestones achieved - TradingViewTradingView · Wed, 05 Aug 2026 13:02:44 GMT